
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
The World Health Organization’s evidence-based recommendations aim to improve care and outcomes for pregnant women with sickle cell disease.
New evidence-based guidelines have been published by the World Health Organization (WHO) for treating sickle-cell disease (SCD) in pregnant women, according to an article published in Pregnancy.1





